GB0718972D0
(en )
2007-11-07
Compounds and methods of making the compounds
IL208607A0
(en )
2010-12-30
Improved nanobodiestm for the treatment of aggregation-mediated disorders
PL1940839T3
(en )
2013-12-31
PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kalpha
ZA200710643B
(en )
2008-11-26
Lipases for pharmaceutical use
EP1901733A4
(en )
2011-06-15
Use of huperzine for disorders
ZA200810703B
(en )
2009-10-28
Compounds having a potentiating effect on the activity of ethionamide and uses thereof
IL185757A0
(en )
2008-01-06
Methods of decreasing calcifcation
MY145179A
(en )
2011-12-30
Use of tetrahydrobenzoxazines as stabilizers
EP1912921A4
(en )
2010-12-08
Tetraazaporphyrin-based compounds and their uses
HK1161122A1
(en )
2012-08-24
Use of 24-norudca 24-norudca
ZAA200501790S
(en )
2006-07-11
Carabiners
ZA200804681B
(en )
2009-11-25
Inhibitors of C-Met and uses thereof
ZA200805711B
(en )
2009-11-25
Solid biocidal compositions and methods of using the same
EP1967210A4
(en )
2009-11-11
Novel application of apelin
ZAA200501788S
(en )
2006-07-25
Carabiners
EP1931370A4
(en )
2010-11-17
Use of des-aspartate-angiotensin i
ZA200706455B
(en )
2009-02-25
Prevention of thrombotic disorders with active vitamin D compounds or mimics thereof
EP1954817A4
(en )
2008-12-03
Kifs as modifiers of the rho pathway and methods of use
GB0516290D0
(en )
2005-09-14
The game of nudgery
GB0510013D0
(en )
2005-06-22
Interaction of SNEV
GB0509511D0
(en )
2005-06-15
Modified polymerases having reduced exonuclease activity
GB0624636D0
(en )
2007-01-17
Self shutting doors-mechanical type area of the techniques
AU2005900435A0
(en )
2005-02-17
Stop splash
PL380549A1
(en )
2008-03-17
The manner of running floatation
GB0412138D0
(en )
2004-06-30
Definition of zeroclick